DCF, M&A and Pharmaceutical - Investment Banking Today

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

DCF

M&A

Pharmaceutical

Factors impacting Perpetual Growth Rate in a DCF

Wizenius

JUNE 28, 2023

One critical aspect is determining the appropriate growth rate for the perpetual growth phase in a Discounted Cash Flow (DCF) model. Pharmaceutical Sector: In the pharmaceutical industry, growth rates can be influenced by factors like patent expirations, drug pipelines, and regulatory approvals.

DCF

DCF Financial Models Financial Modeling Discounted Cash Flow

The Full Guide to Healthcare Private Equity, from Careers to Contradictions

Mergers and Inquisitions

NOVEMBER 1, 2023

When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? Why do PE firms operate there? Don’t they need companies with stable cash flows? In most of the world, healthcare is either government-run or a mixed public/private sector. For example, in the U.S.,

Private Equity

Private Equity Healthcare Equities Middle Market

Factors impacting Perpetual Growth Rate in a DCF

The Full Guide to Healthcare Private Equity, from Careers to Contradictions

Stay Connected